How Cells Avoid Errors When Manufacturing mRNA
A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
GEN1 天
Accelerating mRNA Vaccine Production
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...
The spliceosome: An atomic-level look into how cells avoid errors when manufacturing mRNA
A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
Maravai Lifesciences stock hits 52-week low at $4.19
Maravai Lifesciences Holdings Inc (MRVI) stock has reached a new 52-week low, touching down at $4.19, representing a steep 64% decline from its 52-week high of $11.55. The $1.09 billion market cap ...
FiercePharma7 小时
Rovi warns analyst profit consensus is too high, cites CDMO slowdown
Spanish CDMO Laboratorios Farmacéuticos Rovi, known simply as Rovi, is part of a parade of biopharma contractors struggling ...
The Observer1 天
Ugandan secures US patent for cancer treatment
In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...
FiercePharma7 天
Quantoom, DNA Script and EVA Pharma unite on Africa mRNA project
While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 ...
idw6 天
Spliceosome: How Cells Avoid Errors When Manufacturing mRNA
So the cells are able to “read” the instructions for building proteins stored in these genetic mosaic particles, they are first copied into precursors of mRNA, or messenger RNA. The ...
TriLink, Aldevron enter into license and supply pact for CleanCap
TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...